July 7, 2022

Abata Therapeutics to Participate in the Guggenheim I&I Spotlight Series – Treg-Based Therapies

Abata in the News

Abata Therapeutics to Present at Upcoming Investor Conferences

Press Release
June 2, 2022

Abata Therapeutics Appoints Sandy Lazzari as Chief People Officer

Press Release
April 28, 2022

Abata Announces Formation of Advisory Board Comprised of Leading Industry Experts in Treg Biology, Cell Therapy and Corporate Development

Press Release
April 6, 2022

Does It Matter Where You Locate Your Biopharma Anymore?

Life Science Leader
December 3, 2021

Treg engineers take aim at autoimmunity

Nature Biotechnology
November 9, 2021

Abata Therapeutics Strengthens Board of Directors

Press Release
July 28, 2021

A Potential Transformational Therapy for Progressive MS

RealTalk MS
July 21, 2021

Cell therapy startup Abata launches with $95 million in funding

C&EN
June 23, 2021

How Abata new strategy in non-relapsing MS? Third Rock leads $95M series A

BioWorld
June 23, 2021

Abata: engineering targeted Treg cell therapies with TCRs

BioCentury
June 23, 2021